HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Senores Pharmaceuticals gets marketing authorizations for 10 products
Dec-05-2025

Senores Pharmaceuticals has received marketing authorizations from the Philippine Food and Drug Administration (FDA) for a basket of 10 products across Therapies like Cardiovascular, CNS, and Pain management, etc. This milestone marks a significant step in the company’s strategy to expand its footprint in Southeast Asia and enhance access to affordable healthcare.

The approvals provide Senores Pharmaceuticals with a strong platform to serve the Philippines. The market size of these particular drugs in the Philippines is valued at $23 million, underscoring the immense opportunity for growth and patient impact. With these regulatory endorsements, strong manufacturing capabilities, Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region, leveraging its expertise, global partnerships, and uncompromising quality standards to improve treatment outcomes and broaden patient access.

Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.

  RELATED NEWS >>